WHO calls for manufacturers to submit mpox diagnostic tests for Emergency Use Listing

FHS
August 29, 2024
11:57 pm

WHO has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL).

WCLC roundup: AstraZeneca, Amgen, J&J and Hutchmed tout new combination or confirmatory data

The World Congress on Lung Cancer took place this year from Sept. 9-12 in Singapore. Endpoints News bought you breaking coverage of key data releases

September 13, 2023

CUNY and Pfizer launch new project to track acute respiratory infections across the United States

The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH) and the CUNY Graduate School of Public Health and Health

March 5, 2024

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study | Psychedelic Finance

The research conducted at Cedar Clinical Research in Draper is part of the first ever phase 3 program of psilocybin therapy, and the largest of

June 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.